Search

Jurij Holinej Phones & Addresses

  • 525 Phillips Rd, Montrose, PA 18801 (570) 278-5039
  • 13 Rr 2, Montrose, PA 18801 (570) 278-5039
  • 5 Brantwood Ter, Hackettstown, NJ 07840
  • Newark, DE
  • Lehighton, PA
  • Philadelphia, PA

Work

Company: Lourdes hospital Sep 2007 Position: Pharmacist

Education

Degree: Masters School / High School: Philadelphia College of Pharmacy

Industries

Hospital & Health Care

Professional Records

License Records

Jurij Holinej

Address:
Montrose, PA 18801
License #:
RP031192L - Active
Category:
Pharmacy
Type:
Pharmacist

Resumes

Resumes

Jurij Holinej Photo 1

Pharmacist

View page
Location:
P/O Box 157, Montrose, PA
Industry:
Hospital & Health Care
Work:
Lourdes Hospital
Pharmacist
Education:
Philadelphia College of Pharmacy
Masters
Philadelphia College of Pharmacy
Doctorates, Doctor of Philosophy, Philosophy
Philadelphia College of Pharmacy
Bachelors, Pharmacy

Publications

Us Patents

Pharmaceutical Composition

View page
US Patent:
20020061932, May 23, 2002
Filed:
Sep 11, 2001
Appl. No.:
09/950538
Inventors:
Alberto Gimona - Basel, CH
Richard Macerata - Summit NJ, US
Jasper Huels - Huningue, FR
Eimear Nic Lochlainn - Dublin, IE
Argeris Karabelas - Princeton NJ, US
Simon Bateman - Randolph NJ, US
Jurij Holinej - Hackettstown NJ, US
Anees Karnachi - Hillsborough NJ, US
Maha Khaled - Livingston NJ, US
Victor Sloan - Scotch Plains NJ, US
Sumedha Jayawardene - Bridgewater NJ, US
International Classification:
A61K031/195
US Classification:
514/567000
Abstract:
A method of treating a cyclooxygenase-2 dependent disorder or condition comprising administering 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof in an amount effective to treat such a disorder or condition for about 24 hours, comprising administering orally once a day to a human in need of such treatment one or more immediate release pharmaceutical compositions comprising 5-methyl-2-(2′-chloro-6′fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof, and compositions suitable for use in such methods.

Pharmaceutical Composition

View page
US Patent:
20030171437, Sep 11, 2003
Filed:
Mar 6, 2003
Appl. No.:
10/383041
Inventors:
Jurij Holinej - Hackettstown NJ, US
Yatindra Joshi - Princeton NJ, US
Anees Karnachi - Hillsborough NJ, US
Maha Khaled - Livingston NJ, US
International Classification:
A61K031/195
US Classification:
514/567000
Abstract:
A method of treating a cyclooxygenase-2 dependent disorder or condition comprising administering a solid formulation of 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid which has a residual moisture within predetermined levels.

Pharmaceutical Composition

View page
US Patent:
20040186179, Sep 23, 2004
Filed:
Mar 24, 2004
Appl. No.:
10/807734
Inventors:
Alberto Gimona - Basel, CH
Richard Macerata - Summit NJ, US
Jasper Huels - Huningue, FR
Eimear Nic Lochlainn - Dublin, IE
Argeris Karabelas - Princeton NJ, US
Simon Bateman - Randolph NJ, US
Jurij Holinej - Hackettstown NJ, US
Anees Karnachi - Hillsborough NJ, US
Maha Khaled - Livingston NJ, US
Victor Sloan - Scotch Plains NJ, US
Sumedha Jayawardene - Bridgewater NJ, US
International Classification:
A61K031/195
US Classification:
514/567000
Abstract:
A method of treating a cyclooxygenase-2 dependent disorder or condition comprising administering 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof in an amount effective to treat such a disorder or condition for about 24 hours, comprising administering orally once a day to a human in need of such treatment one or more immediate release pharmaceutical compositions comprising 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid or a pharmaceutically acceptable salt thereof, and compositions suitable for use in such methods.

Pharmaceutical Compositions

View page
US Patent:
20050123604, Jun 9, 2005
Filed:
Mar 6, 2003
Appl. No.:
10/506821
Inventors:
Anees Karnachi - Hillsborough NJ, US
Maha Khaled - Livingston NJ, US
Jurij Holinej - Hackettstown NJ, US
Yatindra Joshi - Princeton NJ, US
International Classification:
A61K031/195
A61K009/20
US Classification:
424464000, 514567000
Abstract:
A method of treating a cyclooxygenase-2 dependent disorder or condition comprising administering 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid in an amount effective to treat such a disorder or condition for about 24 hours, comprising administering orally once a day to a human in need of such treatment one or more immediate release pharmaceutical compositions comprising 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid, and compositions suitable for use in such methods.

Pharmaceutical Composition

View page
US Patent:
20070087051, Apr 19, 2007
Filed:
Dec 14, 2006
Appl. No.:
11/639172
Inventors:
Jurij Holinej - Hackettstown NJ, US
Yatindra Joshi - Princeton NJ, US
Anees Karnachi - Hillsborough NJ, US
Maha Khaled - Livingston NJ, US
International Classification:
A61K 9/20
A61K 31/195
US Classification:
424464000, 514567000
Abstract:
A method of treating a cyclooxygenase-2 dependent disorder or condition comprising administering a solid formulation of 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid which has a residual moisture within predetermined levels.

Solid Pharmaceutical Compositions Comprising Lumiracoxib

View page
US Patent:
20090149543, Jun 11, 2009
Filed:
Feb 6, 2009
Appl. No.:
12/366989
Inventors:
Anees Abdulquadar Karnachi - Hillsborough NJ, US
Maha Y. Khaled - Livingston NJ, US
Jurij Holinej - Hackettstown NJ, US
Yatindra Joshi - Princeton NJ, US
International Classification:
A61K 31/195
C07C 229/40
A61P 29/00
US Classification:
514567, 562456
Abstract:
A method of treating a cyclooxygenase-2 dependent disorder or condition comprising administering 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid in an amount effective to treat such a disorder or condition for about 24 hours, comprising administering orally once a day to a human in need of such treatment one or more immediate release pharmaceutical compositions comprising 5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid, and compositions suitable for use in such methods.

Crosslinked Carboxymethyguar Tablet Disintegrant

View page
US Patent:
49700782, Nov 13, 1990
Filed:
May 25, 1989
Appl. No.:
7/356852
Inventors:
Jurij Holinej - Newark DE
Assignee:
Aqualon Company - Wilmington DE
International Classification:
A61K 920
US Classification:
424465
Abstract:
Tablets containing 1-2% by weight carboxymethylguar as a disintegrant are equivalent to tablets containing sodium carboxymethylcellulose in medicant release. These tablets can be made at a lower cost while still meeting Pharmacopeia standards.
Jurij J Holinej from Montrose, PA, age ~66 Get Report